Pharma's Almanac TV
PA TV
Follow the Journey
Become a Sponsor
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
Rooster Bio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
COVID-19
149 Articles Available
1
7
Can't find what you're looking for? Try our
advanced search
.
COVID-19
Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India
PR-M09-20-NI-17
Oral COVID-19 Vaccine
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine
PR-M09-20-NI-19
COVID-19 Vaccine
Pfizer and BioNTech Announce Data from Preclinical Studies of COVID-19 Vaccine Candidate
PR-M09-20-NI-15
Diagnostic
LabCorp Launches First Combined Test for COVID-19, Flu and RSV in Time for Flu Season
PR-M09-20-NI-13
COVID-19 Vaccine Supply
CSL to Manufacture and Supply University of Queensland and Oxford University Vaccine Candidates for Australia
PR-M09-20-NI-10
COVID-19
Biopharma Leaders Unite to Stand with Science
PR-M09-20-NI-11
COVID-19 Vaccine
AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine
PR-M09-20-NI-08
COVID-19
CureVac Expected to Receive up to 252 million Euros from the German Federal Ministry of Research for Further COVID-19 Vaccine Development
PR-M09-20-NI-05
Clinical Trials
Hackensack Meridian Health Enrolling Individuals for COVID-19 Vaccine Clinical Trial
PR-M08-20-NI-50
COVID-19
Gilead’s Remdesivir Receives FDA Emergency Use Authorization for the Treatment of Patients With Moderate COVID-19
PR-M08-20-NI-48
COVID-19 Vaccine
Moderna Confirms Advanced Discussions with European Commission to Supply Europe with 80 Million Doses of mRNA Vaccine Against COVID-19
PR-M08-20-NI-42
COVID-19 Vaccine
Catalent Signs Agreement with AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine AZD1222
PR-M08-20-NI-41
COVID-19 Treatment
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION Therapeutics for COVID-19 Treatment
PR-M08-20-NI-40
COVID-19
QIAGEN to Launch Digital SARS-CoV-2 Antibody Test
PR-M08-20-NI-37
COVID-19 Treatment
AeroNabs Promise Powerful, Inhalable Protection Against COVID-19 Inspired by Llamas
PR-M08-20-NI-29
Diagnostic Testing
FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect COVID-19 Test
PR-M08-20-NI-27
Vaccine
European Commission Concludes Further Talks to Secure J&J COVID-19 Vaccine
PR-M08-20-NI-24
Donation
Mylan and Sesame Workshop Partner to Provide Socio-Emotional Support Resources to Families Impacted by COVID-19
PR-M08-20-NI-22
Collaboration
Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate
PR-M08-20-NI-19
COVID-19 Treatment
Neutrolis Announces Development of First-In-Class Treatment Targeting Neutrophil Extracellular Traps (NETs) for Patients With Severe COVID-19
PR-M08-20-NI-15
COVID-19 Clinical Trials
RLF-100 Clinical Trial Shows Rapid Recovery from Respiratory Failure Due to Coronavirus
PR-M08-20-NI-14
COVID-19 Vaccine
AstraZeneca Signs COVID-19 Vaccine Deal with Chinese Company
PR-M08-20-NI-12
COVID-19 Vaccine
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
PR-M08-20-NI-11
COVID-19 Vaccine
Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine
PR-M08-20-NI-03
1
7
»
